
Plexus (PLXS) Stock Forecast & Price Target
Plexus (PLXS) Analyst Ratings
Bulls say
Plexus is a well-diversified company with a strong focus on compliance and manufacturing, making them well-positioned for growth in the defense sector and future defense spending. Despite a potential slowdown in healthcare growth, the company is still expected to see strong organic growth thanks to operational efficiency improvements and investments in new technology. With a diverse customer base and potential for outgrowing competitors in growing markets like A&D, Semi Cap, and Data Centers, the company is poised for a successful year ahead. However, potential risks such as economic slowdown and manufacturing disruptions should be closely monitored.
Bears say
Plexus is in a strong position for growth with their diversified portfolio which includes life-saving medical devices, aerospace and defense products, and industrial automation systems, however, the negative outlook is driven by concerns of a slowdown in the APAC segment, which accounts for the majority of their revenue. Despite recent wins and a strong backlog, higher operating margins and programs sizes may not be sustainable in the long term, and the company may face challenges in maintaining their current level of profitability. There are also concerns about the company's capital allocation and potential for overinvestment in technology and automation, as well as the potential impact of rising compensation costs on margins.
This aggregate rating is based on analysts' research of Plexus and is not a guaranteed prediction by Public.com or investment advice.
Plexus (PLXS) Analyst Forecast & Price Prediction
Start investing in Plexus (PLXS)
Order type
Buy in
Order amount
Est. shares
0 shares